Skip to main content

Table 1 Basal characteristics of the study population

From: Increased cardiovascular mortality in females with the a/a genotype of the SNPs rs1478604 and rs2228262 of thrombospondin-1

Variable Males Females p-values
n 239 231  
Age, years (SD) 77 (3) 77 (4) 0.61
History
 Diabetes, n (%) 85 (35.6) 68 (29.4) 0.16
 Hypertension, n (%) 173 (72.4) 184 (79.7) Χ2:4.28
P = 0.04
 IHD, n (%) 66 (27.6) 44 (19.0) Χ2:4.81
P = 0.03
 Atrial fibrillation, n (%) 28 (11.7) 18 (7.8) 0.15
 NYHA I, n (%) 117 (49.0) 121 (52.4) 0.46
 NYHA II, n (%) 73 (30.5) 64 (27.7) 0.50
 NYHA III, n (%) 48 (20.1) 46 (19.9) 0.96
 NYHA IV, n (%) 0 0  
Medication
 Beta blockers, n (%) 90 (37.7) 78 (33.8) 0.38
 ACEI/ARB, n (%) 62 (25.9) 60 (26.0) 0.99
 Diuretics, n (%) 77 (32.2) 95 (41.1) Χ2:4.02
P = 0.05
Examinations
 BP systolic, mm Hg, mean (SD) 146 (23) 151 (19) P = 0.34
 BP diastolic, mmHg, mean (SD) 75 (12) 75 (10) 0.80
 Hb < 120 g/L, n (%) 18 (7.5) 33 (14.3) Χ2:5.54
P = 0.02
 EF < 40%, n (%) 27 (11.3) 9 (3.9) Χ2:9.10
P = 0.003
  1. ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, BP blood pressure, EF ejection fraction, IHD ischemic heart disease, NYHA New York Heart Association functional class, SD standard deviation